These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28392397)

  • 1. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
    Lian H; Cheng Y; Wu X
    Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway.
    Zhang Y; Chen X; Yuan L; Zhang Y; Wu J; Guo N; Chen X; Liu J
    Biochem Biophys Res Commun; 2018 Nov; 506(3):529-535. PubMed ID: 30361091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
    Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
    Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Liu X; Jiang L; Zeng H; Gao L; Guo S; Chen C; Liu X; Zhang M; Ma L; Li Y; Qi X; Wu Y
    Autophagy; 2024 May; 20(5):1072-1097. PubMed ID: 38050963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
    Huang M; Yang Y; Chen Y; Li Y; Qin S; Xiao L; Long X; Hu K; Li Y; Ying H; Ding Y
    J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor 1 knockdown attenuates high glucose-induced podocyte injury by promoting the JAK2/STAT signalling-mediated autophagy.
    Zhang Y; Liu M; Wu Y; Xu Y; Hong Y; Xiang H
    Nephrology (Carlton); 2024 Jul; 29(7):394-404. PubMed ID: 38586891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 16. Formyl peptide receptor 1 promotes podocyte injury through regulation of mitogen-activated protein kinase pathways.
    Zhang J; Ding T; Tang D; Wang J; Huang P
    Exp Biol Med (Maywood); 2022 Jan; 247(2):87-96. PubMed ID: 34565207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MiR-34a alleviates podocyte injury in mice with diabetic nephropathy by targeted downregulation of Notch signaling pathway].
    Wang H; Liu H; Zhang Y; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1839-1845. PubMed ID: 36651252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F; Sheng XX; Zhang HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy.
    Lin Y; Shao Z; Zhao M; Li J; Xu X
    Biochem Biophys Res Commun; 2021 Apr; 550():62-69. PubMed ID: 33684622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.